Diflunisal
규격
22494-42-4CAS 번호
245-034-9EC 번호
5-(2,4-difluorophenyl)-2-hydroxybenzoic acidIUPAC 명칭
C13H8F2O3화학식
250.2 g/mol분자량
diflunisal; 22494-42-4; Dolobid; Dolobis; Flovacil; 5-(2,4-Difluorophenyl)salicylic acid; Diflunisalum; 5-(2,4-difluorophenyl)-2-hydroxybenzoic acid; [1,1'-Biphenyl]-3-carboxylic acid, 2',4'-difluoro-4-hydroxy-; 2',4'-Difluoro-4-hydroxy-3-biphenylcarboxylic acid; 2-(Hydroxy)-5-(2,4-difluorophenyl)benzoic acid; DTXSID5022932; 2',4'-difluoro-4-hydroxy-[1,1'-biphenyl]-3-carboxylic acid; MK647; NSC-756728; 7C546U4DEN; 2',4'-Difluoro-4-hydroxy-(1,1'-biphenyl)-3-carboxylic acid; (1,1'-Biphenyl)-3-carboxylic acid, 2',4'-difluoro-4-hydroxy-; CHEBI:39669; DTXCID702932; Dolocid; Novo-Diflunisal; Apo-Diflunisal; Nu-Diflunisal; NovoDiflunisal; ApoDiflunisal; NuDiflunisal; Apo Diflunisal; Novo Diflunisal; Nu Diflunisal; Dolobid 500; RefChem:56757; N02BA11; 245-034-9; Fluniget; Fluodonil; Adomal; Flustar; MK-647; Diflusinal; MK 647; MFCD00057834; 5-(2,4-DIFLUOROPHENYL)-2-HYDROXY-BENZOIC ACID; 2',4'-difluoro-4-hydroxybiphenyl-3-carboxylic acid; 2',4'-Difluoro-4-hydroxy[1,1'-biphenyl]-3-carboxylic acid; CHEMBL898; 2',4'-difluoro-4-hydroxy-biphenyl-3-carboxylic acid; MLS000028678; Algobid; Citidol; Difludol; Dolobil; Noaldol; Reuflos; 3-BIPHENYLCARBOXYLIC ACID, 2',4'-DIFLUORO-4-HYDROXY-; Unisal; NCGC00016765-01; Dolisal; SMR000058723; CAS-22494-42-4; Diflunisalum [INN-Latin]; 1FL; Dolobid (TN); SR-01000003165; EINECS 245-034-9; BRN 2654431; UNII-7C546U4DEN; Attrogy; Diflunisal (JAN/USP/INN); Diflunisal CRS; Prestwick_168; Diflunisal [USAN:USP:INN:BAN:JAN]; Diflunisal (Standard); Spectrum_000962; DIFLUNISAL [MI]; Opera_ID_803; DIFLUNISAL [INN]; DIFLUNISAL [JAN]; Prestwick0_000039; Prestwick1_000039; Prestwick2_000039; Prestwick3_000039; Spectrum2_001012; Spectrum3_000392; Spectrum4_000513; Spectrum5_000901; DIFLUNISAL [USAN]; DIFLUNISAL [VANDF]; Epitope ID:613463; DIFLUNISAL [MART.]; SCHEMBL4337; DIFLUNISAL [USP-RS]; DIFLUNISAL [WHO-DD]; BSPBio_000137; BSPBio_002203; KBioGR_001085; KBioSS_001442; MLS001146895; BIDD:GT0063; DivK1c_000938; SPECTRUM1500245; SPBio_001163; SPBio_002058; Diflunisal, analytical standard; BPBio1_000151; GTPL7162; orb1225603; orb1310272; orb3025662; DIFLUNISAL [EP IMPURITY]; DIFLUNISAL [ORANGE BOOK]; SCHEMBL18096517; SCHEMBL29367380; SCHEMBL30509654; HMS502O20; KBio1_000938; KBio2_001442; KBio2_004010; KBio2_006578; KBio3_001423; DIFLUNISAL [USP IMPURITY]; MSK7163; NINDS_000938; DIFLUNISAL [USP MONOGRAPH]; GLXC-20635; HMS1568G19; HMS1920G10; HMS2090C16; HMS2091M20; HMS2095G19; HMS3259G17; HMS3712G19; HMS3885H10; HMS5083D21; Pharmakon1600-01500245; Tox21_110598; BDBM50240510; CCG-40230; EBC-26319; HY-18342R; NSC756728; s4609; SBB058143; AKOS005762917; Tox21_110598_1; DB00861; FD16025; KS-1346; NC00506; NSC 756728; IDI1_000938; NCGC00016765-02; NCGC00016765-03; NCGC00016765-04; NCGC00016765-05; NCGC00016765-06; NCGC00016765-08; NCGC00016765-09; NCGC00016765-12; NCGC00022783-03; NCGC00022783-04; HY-18342; SY106650; SBI-0051347.P003; DB-045934; AB00051969; CS-0007468; D5875; NS00009099; ST51014978; C01691; D00130; AB00051969-12; AB00051969_13; EN300-3232727; F031599; 2',4'-difluoro-4-hydroxybipheny-3-carboxylic acid; 2'-4'-Difluoro-4-hydroxybiphenyl-3-carboxylic acid; Q2602750; SR-01000003165-2; SR-01000003165-3; BRD-K22031190-001-05-3; BRD-K22031190-001-13-7; BRD-K22031190-001-23-6; Diflunisal, European Pharmacopoeia (EP) Reference Standard; 2',4'-Difluoro-4-hydroxy-(1',1-diphenyl)-3-carboxylic acid; Diflunisal, United States Pharmacopeia (USP) Reference Standard; 2 inverted exclamation mark ,4 inverted exclamation mark -Difluoro-4-hydroxybiphenyl-3-carboxylic Acid동의어
